Byrnes Michael 4
4 · CERO THERAPEUTICS HOLDINGS, INC. · Filed Dec 4, 2024
Insider Transaction Report
Form 4
Byrnes Michael
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-12-02+127,500→ 127,500 totalExercise: $0.10Exp: 2034-09-30→ Common Stock (127,500 underlying)
Footnotes (1)
- [F1]On October 1, 2024, the Reporting Person was granted an option to purchase 255,000 shares of Common Stock, which vest in two equal installments subject to the satisfaction of certain performance criteria. On December 2, 2024, the Issuer's Board of Directors confirmed that the performance criteria had been met with regards to one installment, resulting in the vesting of 127,500 shares.